Roelmi HPC, a specialist in probiotics, has taken its first step into the personal care market with a skin care active called EquiBiotics LRh. This is a probiotic-derived ingredient obtained by the tyndallisation of L. rhamnosus LRH020
Roelmi HPC, a specialist in probiotics, has taken its first step into the personal care market with a skin care active called EquiBiotics LRh. This is a probiotic-derived ingredient obtained by the tyndallisation of L. rhamnosus LRH020, which is selected for its strain-specific activity focused on the protection from skin pathogens and the modulation of the immune response.
The company said that EquiBiotics LRh “demonstrates high performing efficacy towards multifactorial aggressive agents, such as UV rays, chemical agents” and also helps to prevent pathogen colonisation. It can thus strengthen the skin barrier and its natural defences, indirectly offering such secondary benefits as moisturisation, skin elasticity and wrinkle reduction.
In tyndallisation technology, strains are inactivated by subjecting them to a gentle-heat treatment, leaving them unable to metabolise and reproduce. Because of their prebiotic effect, tyndallised probiotics become nourishment and metabolic support for resident microbiota growth, according to Roelmi.
